Use of ASA after warfarin for unprovoked VTE.
نویسندگان
چکیده
Tools for Practice articles in Canadian Family Physician (CFP) are adapted from articles published on the Alberta College of Family Physicians (ACFP) website, summarizing medical evidence with a focus on topical issues and practice-modifying information. The ACFP summaries and the series in CFP are coordinated by Dr G. Michael Allan, and the summaries are co-authored by at least 1 practising family physician and are peer reviewed. Feedback is welcome and can be sent to [email protected]. Archived articles are available on the ACFP website: www.acfp.ca. Use of ASA after warfarin for unprovoked VTE
منابع مشابه
Continuing Warfarin for 18 Months After Unprovoked PE Reduces Risk of Recurrent VTE.
Synopsis Patients with unprovoked VTE have a higher risk of recurrence than those with a provoked event. This is the first study to evaluate extended anticoagulation beyond six months for patients with unprovoked PE. The authors enrolled adults (N = 371), 18 years or older, who received six months of therapy with a vitamin K antagonist following their first episode of symptomatic unprovoked PE....
متن کاملLiterature Highlight: Preventing Recurrent Venous Thromboembolism with Low-Dose Aspirin
Unprovoked venous thromboembolism (VTE) warrants anticoagulant therapy for a brief period of weeks to months. After it is discontinued, the risk of recurrent VTE remains high. Long-term warfarin therapy is highly effective in preventing recurrence, but it has an increased risk of bleeding, and the monitoring requirements make it inconvenient and costly for patients. Low-dose aspirin is a propos...
متن کاملShould lifelong anticoagulation for unprovoked venous thromboembolism be revisited?
Venous thromboembolism [VTE] is a common medical condition that has significant morbidity and mortality. Although stringent guidelines recommend lifelong anticoagulation for patients with unprovoked VTE, the optimal management strategy for their long term treatment remains controversial. Whereas in cancer-associated VTE and second unprovoked VTE lifelong anticoagulation is universally accepted,...
متن کاملNovel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions
The first-line treatment of venous thromboembolisms (VTE) is anticoagulant therapy, and unfractionated heparin and warfarin are used in Japan. However, as both drugs require dosage adjustments that are difficult, VTE recurrences occur relatively frequently, and hemorrhagic complications are extremely common. The parenteral factor Xa inhibitor fondaparinux and the direct oral anticoagulants (DOA...
متن کاملACP Journal Club. Aspirin did not reduce recurrence after a first-ever, unprovoked venous thromboembolism.
Setting: 56 sites in 5 countries. Patients: 822 patients ≥ 18 years of age (median age 54 y, 54% men) who had a first-ever, unprovoked, symptomatic deep venous thrombosis (DVT) (popliteal vein or more proximal leg veins) or acute pulmonary embolism (PE); and completed 6 to 12 months of anticoagulant therapy with warfarin. Exclusion criteria included > 2 years since VTE; other indications or con...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Canadian family physician Medecin de famille canadien
دوره 59 10 شماره
صفحات -
تاریخ انتشار 2013